R&D May 2012
Merck Serono’s key research areas and pipeline compounds
Our R&D pipeline covers a range of projects in our therapeutic areas from Phase I through to Registration. From first-in-man administration through to commercialization, we are currently pursuing clinical studies involving thousands of patients around the world. Our teams provide global support to achieve rapid regulatory approvals, as well as post-approval and life-cycle initiatives, allowing us to achieve and maintain approximately 4,500 marketing authorizations in more than 130 countries.
